Bayanan Kamfanin
Innovita Biological Technology Co., Ltd. (tare da rassansa, wanda aka fi sani da "INNOVITA",) kamfani ne na ilimin halittu wanda ke mai da hankali kan bincike, haɓakawa, samarwa da siyar da samfuran POCT na in vitro diagnostic. Ya ƙunshi Innovita (Tangshan) , Innovita (Beijing) da Innovita (Guangzhou).
● An kafa shi a cikin 2006
● Kafa cibiyoyin R&D a Beijing da Guangzhou, da cibiyar samar da kayayyaki a Qian'an, Hebei.
Bayanan Kamfanin
An kafa shi a cikin 2006, INNOVITA ta gina dandamali na fasaha guda shida irin su antigen & shirye-shiryen antibody, al'adun ƙwayoyin cuta, zinare na colloidal, ELISA, chromatography mai haske, immunofluorescence, da aiwatar da shirin R&D na babban fasaha na kasar Sin a fannin bincike kan manyan cututtukan cututtuka na kasa da yawa. sauran ayyukan kiwon lafiyar jama'a.Bayan haka, INNOVITA tana da haƙƙin ƙirƙira sama da goma na ƙasa kuma ta kafa cibiyar R&D ta Beijing, cibiyar R&D ta Guangzhou, tushen samar da Hebei.Tare da manyan tarurruka masu tsabta, da kafa zinari na colloidal, ELISA, chromatography na fluorescence, PCR, layin samar da immunofluorescence, INNOVITA ta sami CE da ISO13485 takardar shaida.
A halin yanzu, samfuran INNOVITA sun ƙunshi gwaje-gwajen gano numfashi, gwajin haihuwa, gwajin hanta, gwajin TORCH, gwajin jini na zuciya, gwajin aikin koda da sauransu.Cibiyar sadarwar tallace-tallace ta shafi dukkan larduna da yankuna na kasar Sin, kuma ta bazu zuwa kudu maso gabashin Asiya, Gabas ta Tsakiya, Afirka, Latin Amurka, Tarayyar Turai da sauran yankuna na ketare.INNOVITA tana manne da falsafar kasuwanci ta tsakiya ta abokin ciniki, kuma tana hidimar abokan ciniki tare da ingantattun samfura masu dacewa.Bukatun abokan ciniki shine bin INNOVITA.
Tsarin Ci gaba
A shekara ta 2006
A cikin 2011
A cikin 2014
A cikin 2018
● Fara haɗin gwiwar fasaha na duniya.
A cikin 2019
A cikin 2020
● Fitar da shi zuwa ƙasashe / yankuna sama da 70.
● Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararru na Ƙasa don Yaki da Annobar COVID-19.
● Gwajin COVID-19 IgM/IgG ya sami Izinin Amfani da Gaggawa (EUA) ta FDA ta Amurka.
A shekarar 2022
rassan
Cibiyar R&D & Kasuwanci ta Beijing
Kafa:2006
Mayar da hankali:R&D, masana'anta, tallan samfuran in-vitro, gami da dandamali kamar su immunodiagnosis, ganewar ƙwayoyin ƙwayoyin cuta, da guntun kwayoyin halitta.
Cibiyar Masana'antar Qian'an & Logistic
Kafa:2011
Wurin aiki:Rufe wani yanki na 150 acres, a kusa da 8,000 ㎡ yankin bita, sanye take da mahara samar Lines na colloidal zinariya, ELISA, PCR.
Takaddun shaida:ISO 13485, CE, FDA, NMPA, da dai sauransu.
Cibiyar R&D ta Guangzhou
Kafa:2020
Mayar da hankali:R&D na fasahar IVD
Dandalin
Sadarwar Talla
Bayan shekaru na ci gaba, Innovita ya riga ya sami cikakkiyar hanyar sadarwar tallace-tallace da sabis, tare da tashoshin tallace-tallace da suka shafi larduna da yankuna 32 a fadin kasar Sin, kuma sun fitar da su zuwa kasuwannin duniya kamar kudu maso gabashin Asiya, Gabas ta Tsakiya, Afirka, Latin Amurka, Turai, da dai sauransu.
Gwajin Innovita 2019-nCoV Ab da aka nuna akan dandamalin gaggawa na ƙasa don magunguna da na'urorin likitanci
A ranar 28 ga Fabrairu, 2020, firaministan kasar Li Keqiang ya duba dandalin gaggawa na magunguna da na'urorin likitanci na COVID-19.An nuna gwajin Innovita 2019-nCoV Ab azaman farkon NMPA ta amince da gwajin IgM/IgG combo antibody, wanda aka ruwaito akan CCTV.
Gwajin Innovita 2019-nCoV Ab mai suna wanda Masanin Ilimin Zhong Nanshan
A yammacin ranar 23 ga Fabrairu, 2020, masanin ilimin kimiyya Zhong Nanshan ya bayyana yayin wani shawarwari mai nisa a Guangzhou tare da kungiyar likitocin Guangdong da ke gaggawar taimakawa Jingzhou cewa Hukumar Kula da Kayayyakin Magunguna ta Kasa ta amince da sabbin na'urorin gwaji guda biyu na 2019-nCoV, daya daga cikinsu shine. Kamfanin Innovita (Tangshan) Biological Technology Co., Ltd.
● Kit ɗin yana amfani da hanyar zinari na colloidal, wanda zai iya gano maganin rigakafi na lgM a jikin majiyyaci.Ana iya gano maganin rigakafi na lgM a ranar 7th na kamuwa da cutar ko kuma ranar 3rd na farawa, wanda ke taimakawa sosai don ƙarin ganewar asali.Zhong Nanshan ya ce: "Za a iya gano marasa lafiya da sauri don samun kyakkyawar ganewar asali. Wannan zai iya taimaka mana cikin sauri ware mutanen al'ada da masu kamuwa da cutar."
Advanced Collective Award
Yaki da Cutar Kwalara
